Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis Type 1

Explore clinical trials studying Neurofibromatosis Type 1. Study availability and eligibility vary by location and protocol.

59 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis Type 1 trial results

Completed

Selumetinib Paediatric NF1 Japan Study

NCT04495127

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Minatoku, Japan
  • Research Site Nagoya, Japan
  • Research Site Setagaya-ku, Japan
View Trial Details
Completed

Frameshift Peptides of Children With NF1

NCT04212351

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • The University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

NCT02415153

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +33 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions
Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details

Related conditions